Dr. Ian Frazer is a professor at the University of Queensland where he leads a research team working at the Translational Research Institute (TRI) in Brisbane, Australia on the immunobiology of epithelial cancers. Additionally, he currently serves as the President of the Australian Academy of Health and Medical Sciences, and as a member of the Australian National Health and Medical Research Council. He also chairs the Australian Medical Research Advisory Board of the Medical Research Future Fund. In addition to his positions in science and academia, Dr. Frazer serves on the boards of several corporations and not-for-profit organizations, including Jingang Medicine (Aus) Pty Ltd., Microba Pty Ltd and the Frazer Family Foundation. Among his numerous accolades, Dr. Frazer was recognized as Australian of the Year in 2006. He was recipient of the Prime Ministers Prize for Science and the Balzan Prize, both in 2008, followed in 2012 by his election as a Fellow of the Royal Society of London. He was appointed Companion of the Order of Australia in 2013. Dr. Frazer is a named inventor on patents relating to HPV prophylactic and therapeutic vaccines licenced to CSL, Merck & Co. and GlaxoSmithKline (GSK), and on patents on DNA vaccines and on optimizing therapeutic protein expression licensed to Jingang Medicine (Aus) Pty Ltd.